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Binding to and killing of human renal epithelial cells by hemolytic
P-fimbriated E. coli. Acute pyelonephritis is a common invasive infection
frequently caused byE. coli that possess P-fimbriae and secrete hemolysin.
We have examined the role of P fimbriae and hemolysin in the killing of
putative target cells of acute pyelonephritis, that is, human renal epithelial
cells (HRPTEC). Cultures of HRPTEC were overlaid with (1) a proto-
typic pyelonephritogenic E. coli (CFTO73) which expresses both P fimbriae
and hemolysin; (2) its hemolysin-negative isogenic mutant (CFTO73hIyD::
TnphoA); or (3) a prototypic nonpyelonephritogenic fecal E. coli (FN414)
which is negative for both P fimbriae and hemolysin. CFTO73 and
CFTO73h1yD::TnphoA but not FN414 adhered to HRPTEC, as demon-
strated by electron microscopy and direct counting. Adherence was
diminished by antisera directed against P fimbriae and by a monoclonal
antibody recognizing the epithelial receptor for P fimbriae. CFTO73 was
significantly more cytolethal for HRPTEC than its hemolysin-negative
mutant. The bacteria-free filtrate of CFTO73 was both hemolytic and
cytolethal whereas that of CFTO73hyD::TnphoA was not hemolytic and
was significantly less cytolethal. Finally, we demonstrated that CVf073
passed through monolayers of HRPTEC at a higher rate than
CFTO73h1yD::TnphoA, indicating that hemolysin damages HRPTEC, fa-
cilitating passage of bacteria through the epithelial barrier. With
HRPTEC and a pyelonephritogenic strain of E. coli we have reproduced
in vitro bacterial attachment and toxin delivery by P fimbriae and
hemolysin, factors epidemiologically associated with acute pyelonephritis
in patients.
The most common malady of the urinaly tract is bacterial
infection, with acute pyelonephritis representing its most serious
manifestation [1]. Yet the pathogenesis of renal infection is not
well understood. Evidence from epidemiologic studies of Esche-
richia coli (E. coli), the most common organism causing acute
pyelonephritis, suggests that features of the host and of the
bacterium are important in the development of this disease [2].
For example, E. coli from patients with acute pyelonephritis and
abnormalities of the urinaiy tract, such as obstruction, vesi-
coureteral reflux, and indwelling catheters, are frequently indis-
tinguishable from commensal fecal isolates. On the other hand, E.
coli causing acute pyelonephritis in normal urinaly tracts, often
possess genes and gene products uncommon among the usual
fecal strains. These putative virulence factors include specific
fimbriae, hemolysin, aerobactin, and certain capsular and lipo-
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polysaccharide antigens. Among these factors, the two distin-
guished by the highest relative frequency in acute pyelonephritis
are P fimbriae [2—4], found in 70% of acute pyelonephritis (vs.
19% of fecal) strains, and hemolysin [2—5], identified in about
50% of acute pyelonephritis (vs. 12% of fecal) strains.
Bacterial perturbation of the epithelium may be critical to the
development of acute pyelonephritis. The fact that the urinary
tract is the most common source of clinical bacteremia [61
suggests that infecting bacteria interact with and sometimes
invade through renal epithelium. In earlier studies we corrobo-
rated the noted epidemiologic features of E. coli strains causing
acute pyelonephritis in patients, tested the pathogenic potential of
these pyelonephritogenic strains in a mouse model of acute
pyelonephritis, and demonstrated that hemolytic E. co/i strains
were cytolytic for human renal epithelial cells [7]. These experi-
ments led us to the hypothesis that P fimbriae and hemolysin act
in concert to promote epithelial cell damage and to allow pene-
tration of bacteria to deeper tissues. Experiments reported in this
paper explore this hypothesis using genetically defined E. coli
strains and human renal epithelial cells in a variety of in vitro
models. These studies have prompted us to speculate a pathogenic
sequence for the renal infection caused by P-fimbriated, hemolytic
E. coli.
Methods
Human renal epithelial cells
Human renal proximal tubular epithelial cells (HRPTEC).
HRPTEC were isolated, cultured, and characterized as described
previously [8]. Briefly, kidneys obtained at autopsy were perfused
with ethylene glycol-bis-(beta aminoethyl ether) N,N'-tetraacetic
acid to weaken intercellular junctions and then with collagenase
to dissolve the intercellular matrix. Outer cortical tissue was
removed, minced, and further digested with a fresh collagenase
solution. The resultant cell suspension was filtered through 100
.tm nylon mesh to remove glomeruli and the volume of the filtrate
was adjusted to a cell density of 106 cells per ml cell medium
(CM), consisting of Cellgrotm (Eagle's minimum essential me-
dium + L-glutamine; Mediatech, Herndon, Virginia, USA) sup-
plemented with the following constituents obtained from GIBCO
(Grand Island, New York, USA):insulin (1.0 U/ml), heat inacti-
vated fetal bovine serum (10%), amphotericin B (1.25 rg/ ml),
penicillin (1.0 U/ml), streptomycin (100 tg/ml), and HEPES
buffer (10 mM). The primary isolates were then plated and
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incubated at 37°C in an atmosphere of 95% air:5% CO2. Medium
was changed twice weekly. Once confluent, the cells were
trypsinized, concentrated in CM containing 7% dimethylsulfox-
ide, and stored in liquid nitrogen for subsequent use in experi-
ments.
As described previously [8], these human renal cells were
confirmed as proximal tubular epithelial cells. They were shown to
be epithelial in nature by the presence of cytokeratin, demon-
strated by immunoperoxidase staining. Two tests indicated their
proximal tubular source: (1) high gamma glutamyltransferase
activity, a marker for the brush border of HRPTEC, and (2)
binding of peroxidase-labeled winged pea lectin to the L-fucose
moiety of the glycocalyx of HRPTEC. We excluded distal tubular
epithelial origin by absence of staining with peroxidase-labeled
rabbit anti-human Tamm-Horsfall protein and endothelial cell
origin by the absence of staining for Factor VIII activity. By
electron microscopy, the human renal cells exhibited characteris-
tics of epithelial cells, namely junctional complexes and desmo-
somes with associated tonofilameots [9].
Transmission electron microscopy (TEM). Monolayers were
fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer.
After post-fixation with 2% aqueous 0504, they were dehydrated
through an ethanol series, cleared in propylene oxide and embed-
ded in Polybed-812. Ultrathin sections were cut, mounted on
carbon-coated grids, double-stained with uranyl acetate and lead
citrate and examined in a JEOL 1200 EX electron microscope.
Bacteria
Bacterial strains. E. coli CFTO73, originally isolated from the
blood of a woman with a normal urinary tract and acute pyelo-
nephritis, reliably causes acute pyelonephritis in a mouse model of
ascending urinary tract infection. It possesses the genes encoding
P and S fimbriae and hemolysin, as shown by DNA hybridization
with specific gene probes, and expresses the phenotypes associ-
ated with these genes [7].
Using transposon mutagenesis on CFTO73, we isolated a he-
molysin-negative mutant, CFTO73hyD::TnphoA. This mutant is
characterized by a single transposon insertion in hlyD as demon-
strated by Southern blot and is non-hemolytic on 5% sheep blood
agar plates and upon suspended erythrocytes. However, the
mutant remains positive by DNA probe and by phenotypic
expression for P, 5, and type 1 fimbriae [7].
E. coli FN414 is a fecal strain supplied by R. Hull (Baylor
College of Medicine) which we have used as a negative control [7]
for cytotoxicity studies. This strain is negative when tested by
colony blot hybridization with DNA probes for P and S fimbriae
and for hemolysin genes. FN414 does not hemagglutinate human
erythrocytes in the presence of mannose nor cause hemolysis on
blood agar plates. This strain hybridizes with the gene probes
specific for type 1 fimbriae and expresses the product of this
operon, as assayed by mannose-sensitive hemagglutination of
guinea pig erythrocytes.
Bacteria were stored at —70°C in trypticase soy broth (Difco
Laboratories, Detroit, MI) supplemented with 15% (vol/vol)
glycerol.
Hemagglutination. Hemagglutination assays were conducted
with fresh guinea pig and human type 0 erythrocytes to determine
mannose sensitive hemagglutination (type 1 fimbriae) and man-
nose resistant hemagglutination (P, 5, and other fimbriae), respec-
tively. Erythrocytes were washed in PBS and suspended at 3%
(vol/vol) in Alsever's solution. The test was conducted on a white
tile over crushed ice with rocking, using 10 /11 of the bacterial
suspension (1010 cfu/ml) mixed with 10 gl of the erythrocytes.
Bacterial agglutination with alpha-D-Gal-(1-4)-beta-D-Gal (the
receptor for P fimbriae) was tested using coated latex particles
(Orion Diagnostica, Espoo, Finland).
Hemolytic activity. The hemolytic activity of E. coli suspensions
and filtrates was determined by a modification of the method
described by Smith [10]. Supernates or filtrates (100 gl) of
bacterial suspensions were incubated with 1% sheep erythrocytes
(100 1.d) for 1 hr at 37°C. The absorbance of the hemoglobin
released into the supernate upon lysis of erythrocytes was deter-
mined at 550 nm. Hemolytic activity was expressed as a percent of
complete hemolysis of the sheep erythrocytes following incuba-
tion with distilled water for one hour.
Interactions of E. coli with HRPTEC
Bacterial adherence. HRPTEC were grown on chamber slides
(Lab Tek, Nunc, Inc., Naperville, Illinois, USA) to 50% conflu-
ency with approximately 5 x i03 HRPTEC per slide. Except as
noted, bacterial strains were passaged three times by overnight
culture on Luria agar at 37°C, to promote P fimbriae growth [11].
For assays of adherence of CFTO73 to HRPTEC mediated by type
1 fimbriae, bacteria were grown overnight in static Luria broth.
Bacteria were suspended in CM and adjusted so that the absor-
bance at 600 nm (1 cm path length) was equal to 0.22, correspond-
ing to 5 x 108 cfu/ml. One milliliter of the suspensions was added
to each well to obtain an inoculum of io bacteria per HRPTEC.
Slides were incubated at 37°C in a CO2 incubator for one and
three hours, washed three times with PBS, fixed with methanol,
and stained with Giemsa. For assays of type 1-mediated adher-
ence, the slides were incubated for two hours. The number of
adherent bacteria was counted on 50 cells examined in consecu-
tive fields and the mean number of bacteria/cell was averaged over
three experiments.
Adherence inhibition assays were conducted with D-mannose,
rabbit anti-P fimbriae sera, and a mouse monoclonal Gal-Gal
antibody. D-mannose (Sigma Chemicals, St. Louis, Missouri,
USA) was added to the bacterial suspension in CM at a final
concentration of 2.5% (wt/vol), and io CFU/ml CFTO73 were
reincubated with a 1:300 dilution of anti-P sera (supplied by Dr.
Irving Salit, Toronto General Hospital) in CM for 30 minutes at
37°C and then incubated with HRPTEC. HRPTEC were prein-
cubated with monoclonal anti-Gal-Gal antibody (Accurate Chem-
ical, Westhury, Connecticut, USA) diluted 1/50 in CM for 30
minutes at 37°C. The medium was removed and the HRPTEC
were then incubated with io CFTO73/ml and suspended in CM
containing monoclonal anti-Gal-Gal (1:50). Bacteria or cells
incubated with normal rabbit serum at the corresponding dilu-
tions were simultaneously processed as negative controls.
Cytolethality. To study the cytolethality of hemolytic E. coli,
HRPTEC were grown to confluence on 96-well tissue culture
clusters (Costar, Cambridge, Massachusetts, USA). Bacteria were
inoculated onto trypticase soy agar and incubated at 37°C. Colo-
nies were scraped and inoculated into 100 ml of buffer-modified,
low salt Luria broth (per liter, 10 g Baeto tryptone, S g yeast
extract, 0.5 g NaC1, 10 mivi HEPES, pH 7.2); the solution was
adjusted to 300 mOsm as measured on a calibrated osmometer
(Osmette). Cultures were grown at 37°C with aeration (200 rpm)
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Table 1. Adherence of bacterial strains to HRPTEC
Strain Treatmenta MRHAb
GalGalC
agglutination
Adherence to HRPTEC
bacteria/cell"
1 hour 3 hours
CETO73 — + + 27.1 17.7 47.5 23.3
CVFO73hIyD::TnphoA
FN414
—
—
+
—
+
—
35.1 16.6
1.3 2.O
47.0 19.5
2.4 2.7
CFTO73 D-mannose + + 22.6 21.0 46.9 19.8
CFTO73 25Ca — — 5.1 3.2 7.2 6.0
CVFO73 Anti-P fimbriae sera ND ND 7.9 6.7k 18.3 15.7
CFTO73 Anti-Gal-Gal mAb ND ND 10.9 8.6k 30.5 171
a Organisms were grown on Luria agar at 37°C (except as noted) and suspended in PBS for inoculation over HRPTECb MRHA is mannose-resistant hemagglutination of human 0 eiythrocytes
C Gal-Gal is alpha-D-gal (1-4)-beta gal (Orion Diagnostica, Espoo, Finland)
"Data are mean 1 SD of 3 experiments
eGrown at 25°C to suppress expression of P fimbriae
Significantly lower numbers of adherent organisms (P < 0.05) in comparison to CFTO73 grown on Luria agar at 37°C
until the absorbance at 550 nm was equal to 0.9. These suspen-
sions (approximately io CFU/ml) were diluted 1,000-fold in
buffered Luria broth, and overlaid onto the confluent monolayers
of HRPTEC. Infected monolayers were incubated at 37°C for 1,
2.5, 3 and 6 hr prior to viability measurements. In order to
determine bacteria:cell ratios, bacterial counts were performed by
dilution and spreading onto TSA plates and cell counts were
performed on a hemocytometer after trypsinization of the
HRPTEC monolayer. In some experiments, the bacterial dilutions
of 1/1000 were allowed to grow for five hours to maximize
hemolysin production and filtered through 0,22 ,tt low protein
binding filters to produce bacteria-free filtrates prior to incubation
with HRPTEC monolayers.
Epithelial cell viability was estimated by the neutral red inclu-
sion assay of Borenfreund and Peurner [12]. Neutral red was
incorporated into the lysosomes of living cells. After incubation
with bacterial suspensions or cell-free filtrates, HRPTEC were
rinsed with PBS, incubated for three hours at 37°C with neutral
red (50 g/ml), and then rinsed three times with 4% formalde-
hyde-1% CaC12 solution. Dye was extracted with a 1% acetic
acid-50% ethanol solution and the absorbance at 540 nm was
determined using a Dupont Instruments' microtiter plate reader.
Absorbance of each treated monolayer was expressed as a percent
of the absorbance at each time period of HRPTEC incubated in
Luria broth alone. Eight wells per treatment were averaged per
experiment and each experiment, except as noted, was conducted
on at least three separate occasions.
HRPTEC monolayer penetration. To measure penetration of
bacteria through cultured HRPTEC monolayers, we used a
modification of the procedure described by Finlay, Fumbiner, and
Falkow [13]. HRPTEC were trypsinized; adjusted to 5 X io
viable cells per ml of MEM containing 10% fetal bovine serum,
100 tg/ml streptomycin and 100 U/mI penicillin, and inoculated in
0.2 ml volumes into Transwell filters with 3.0 pores (Costar).
Transwell filters were placed in 24-well plates containing 1.0 ml of
the same medium. Cells were incubated in an atmosphere of 95%
air, 5% CO2 with medium changes every 48 hours for five days, by
which time they had reached confluence. On the day of each
experiment, the medium was changed to MEM without additives.
Bacteria were grown shaking overnight in Luria broth, diluted
tenfold in PBS and added in 10 d volumes to the apical surface
of the cells (approximately 2 x 106 CFU). In mixed infections,
fivefold dilutions of each strain were combined and added in 10 p1
volumes. Plates were incubated in an atmosphere of 95% air, 5%
CO2 and, at two hour intervals, filters were transferred to new
wells containing fresh medium. Bacteria that had penetrated the
monolayer to reach the medium in the wells were then quantified
by plate dilution. For mixed infections, the number of CFU of
mutant strain CFTO73h1yD:TnphoA (which is resistant to kanamy-
cm by virtue of the TnphoA transposon) was determined on Luria
agar plates containing kanamycin (50 ig/ml) and the number of
wild-type CFTO73 CFU inferred as the difference between the
CFU on non-antibiotic containing Luria agar plates and on the
kanamycin plates. In each of three experiments, wild-type and
mutant were tested in duplicate separately and in mixed infection.
The results from the three experiments were pooled for analysis.
The transwell filters were subsequently stained with 4% buffered
Giemsa and examined by light microscopy for monolayer integ-
rity.
Results
E. coli adherence to HRPTEC
The association of E. coli with HRPTEC is shown in Table 1.
The pyelonephritogenic strain CFTO73 adhered to the HRPTEC
in relatively high numbers, a mean of 48 bacteria/cell at three
hours. The transposon mutant, CFTO73hyD::TnphoA, identical to
its parent except for lack of hemolysin activity, adhered to
HRPTEC in similar numbers. The fecal strain FN414 adhered to
HRPTEC in significantly lower numbers than the two CFTO73
strains (P < 0.05, Student's 1-test).
The addition of mannose (50 .LM), an inhibitor of binding by
type 1 fimbriae, did not diminish adherence of CFTO73 grown on
Luria agar (Table 1). Similarly, mannose did not inhibit adherence
to HRPTEC of CFTO73 grown in Luria broth to promote
expression of type 1 fimbriae (45.4 5.5 bacteria/cell in controls
vs. 40.9 4.5 in the presence of mannose; P = 0.26, Student's
one-tailed 1-test). When CFTO73 was grown by three passages at
25°C to suppress expression of P fimbriae, the bacteria did not
express mannose-resistant hemagglutination and adherence to
HRPTEC was significantly decreased (P < 0.05). Antibodies to P
fimbriae added to the bacteria and antibodies to the Gal-Gal
moiety present in the glycolipid receptor for P fimbriae added to
.S
I .
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Fig. 1. Electron micrograph of a human renal
proximal tubule cell encircled by a
pyelonephritogenic E. coli strain CFTO73 after 3
hours incubation. Bar = 1.0 pin.
the HRPTEC each significantly (P < 0.05) diminished the adher-
ence of CFTO73 to HRPTEC.
Microscopy
HRPTEC were incubated with each of the three E. coli strains
suspended in Luria broth to encourage bacterial growth and
hemolysin production. After three hours treatment with CFTO73,
virtually all cells were encircled with organisms equidistant from
the cell surface (Fig. 1). Higher magnification revealed fimbriae-
like structures attaching the organisms to the epithelial cell
membrane. Incubation with CFTO73 for six hours caused detach-
ment of most of the HRPTEC from the culture dishes, precluding
further examination.
Observations of the effect of the hemolysin-negative mutant,
CFTO73hyD::TnphoA revealed similar early findings. As with the
parent strain, virtually every HRPTEC was surrounded by organ-
isms attached to its surface by fimbriae (Fig. 2A). However, unlike
the experiments with CFTO73, many HRPTEC persisted through-
out the entire 24 hours of observation with the hemolysin-negative
mutant tethered to them by fimbriae (Fig. 2B). Rarely, an
organism was observed intracellularly within a vacuole.
Treatment with strain FN414, the fecal strain, resulted in very
few bacteria seen extracellularly; no fimbrial attachment of bac-
teria to the HRPTEC was observed. Large numbers of multive-
sicular bodies in the HRPTEC were apparent (Fig. 2C). By 20
hours, many HRPTEC persisted in the wells, some containing
organisms in membrane-bound vacuoles.
Cytolethalily
The observations made by electron microscopy prompted us
to quantify the cyotolethal effects of our strains. After addition
of CFTO73, we observed a lag period of about one hour and
then rapid death of HRPTEC; few epithelial cells remained by
three hours (Fig. 3). In contrast, with the hemolysin-negative
mutant, virtually all HRPTEC were viable at three hours, and
by six hours 70% were still alive. The findings with FN414 were
similar to those made with incubation of CFTO73hyD::TnphoA
with HRPTEC. The hemolysin-negative mutant of CFTO73 was
significantly less cytolethal than its hemolytic parent, but not
different than FN414 at the 5% significance level (Tukey's test).
We examined the dose response of bacterial cytolethality by
varying the number of bacteria applied per epithelial cell. As
demonstrated in Figure 4, survival of HRPTEC at two hours
incubation with CFTO73 was inversely associated with the bacte-
ria:cell ratio. In contrast, experiments with the hemolysin-negative
mutant or FN414 performed on many separate occasions demon-
strated that viability of HRPTEC at two hours did not drop below
90% when the bacteria:cell ratio was varied over the same range.
These experiments demonstrated that CFTO73 was signifi-
cantly more cytolethal for HRPTEC than its hemolysin-nega-
tive mutant, providing strong evidence that hemolysin was the
eytolethal agent. To investigate this further, we exploited the
fact that hemolysin is one of the few proteins secreted byE. coil
[14] and investigated the effects upon HRPTEC of filtrates of
the three bacterial strains. The use of these filtrates also
allowed us to stabilize the dynamics of studies with four living
biologic systems (HRPTEC and the three bacterial strains) in
which bacterial growth rapidly results in marked changes in the
number of bacteria per cell (Fig. 5).
The bacteria-free filtrate of CFTO73 had a hemolytie activity of
86% compared to 0% activity for its isogenic hemolysin-negative
mutant and 0% for the non-hemolytic fecal control strain. Fil-
trates of the three bacteria applied to HRPTEC resulted in the
findings demonstrated in Figure 6. As with the whole organisms,
the filtrate of CFTO73 was distinguished by its marked cytolethal
effect upon HRPTEC, significantly more than the hemolysin-
negative mutant and the fecal strain at all time points at the 5%
significance level (Tukey's test).
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Fig. 2. (A) Electron micrograph of a human renal proximal tubular epithelial cell (HRPTEC) encircled by the hemolysin-negative mutant of pyelonephri-
togenic E. coli Strain CFTO73 (CFTO73hyD::TnphoA) after 3 hours incubation. (B) Enlargement of an area within A in which fimbrial attachments of the
hemolysin-negative mutant to the plasmalemma are apparent. (C) Electron micrograph of two HRPTEC after 3 hours treatment with non-
pyelonephritogenic E. coli strain FN414. Numerous multivesicular bodies are apparent in both cells (arrows). In contrast to treatment with CFTO73 or
CFTO73hyD::TnphoA, no bacteria adhering to ITRPTEC were observed. Bars = 1.0 m.
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Fig. 3. Viability estimated by neutral red inclusion into HRPTEC exposed to
E. coli CFTO73 (•), its hemolysin-negative mutant CFTO73hyD::TnphoA
(0), or FN414 (•). Confluent monolayers were overlaid with E.coli
suspensions of bacteria in buffered isosmolar Luria broth. Absorbance of
each treated monolayer was expressed as a percent of the absorbance of
the Luria broth control at each time period. Each data point represents
the mean 1 SD of three separate experiments except as noted by * whereN = 2.
E. coli penetration of HRPTEC mono/ayers
To investigate the potential contribution of hemolysin to E. co/i
tissue invasion, we studied the ability of E. coli strain CFTO73 and
its hemolysin-negative mutant CFTO73hIyD:TnphoA to penetrate
a monolayer of HRPTEC (Fig. 7). At two and four hours of
incubation, there was no difference in monolayer penetration (P
= 0.15 and P = 0.06 at 2 and 4 his, Student's t-test). However, at
six and eight hours of incubation, CFTO73 penetrated the mono-
layer in significantly greater numbers than the hemolytic-negative
mutant (P = 0.01 for each time point).
We considered two possible explanations for these results. The
greater ability of the parent bacterial strain to penetrate the
monolayer could be the result of a specific transport mechanism
Time, hours
Fig. 5. Changes in the number of bacteria (A), number of epithelial cells
(0), and the ratio of bacteria to epithelial cells during coincubation ([2). The
number of bacteria per ml recovered at various times (solid line) is shown
on the right ordinate, while the number of epithelial cells estimated by
direct counting after tlypsinization (white columns) and the calculated
ratio of bacteria to epithelial cells (shaded columns) are shown on the left
ordinate.
analogous to the transcytosis of salmonella across epithelial cell
barriers [13]. Alternatively, the penetration of CVFO73 may be the
result of the cytolethal effect of hemolysin, leaving breaches in the
epithelial cell barrier through which any bacterium could pass. To
distinguish between these possibilities, we conducted experiments
in which CFTO73 and its hemolysin-negative mutant were added
to the same filter in a mixed infection. The results of these
experiments are shown in Figure 7. In contrast to the significant
difference between recovery of CFTO73 and its mutant when
inoculated separately, there was no significant difference when the
strains were inoculated together in a mixed infection. Further-
more, light microscopic examination of transwell filters stained
with Giemsa revealed that monolayers infected with CFTO73 were
nearly totally destroyed while those infected with CFTO73h/yD::
TnphoA were comparatively well-preserved.
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Fig. 6. VIability estimated by neutral red inclusion into HRPTEC exposed to
bacteria-free filtrates of suspensions of E. coli strains CFTO73 (•), its
hemolysin-negative mutant CFTO73hyD::TnphoA (0), orFN414 (•).
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Fig. 4. A representative experiment demonstrating viability as estimated by
neutral red inclusion into HRPTEC exposed to valying numbers of E. coli
strain CFTO73 for 2 hours.
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Fig. 7. Top: Penetration of E. coli wild-type strain CFTO73 (black columns)
and hemolysin-negative mutant strain CFTO73hyD::TnphoA (white col-
umns) across a monolayer of HRPTEC when inoculated separately. The
number of CFU recovered from the basal side of monolayers was
determined at each time point. The mean and SEM of log-transformed data
from three experiments conducted in duplicate are shown. Bottom:
Penetration of E. co/i wild-type strain CFTO73 (black columns) and
hemolysin-negative mutant strain CFTO73hyD::TnphoA (white columns)
across a monolayer of HRPTEC when inoculatd together. The number of
CFU recoverd fron the basal side of monolayers was determined at each
time point. The mean and SEM of log-transformed data from three
experiments are shown.
Discussion
The development of invasive acute pyelonephritis is complex. If
we assume an ascending route of infection and an intact epithe-
hum, bacterial invasion of the kidney is the result of a number of
sequential steps: Bacteria (1) must gain access to renal epithe-
hum, (2) adhere to the epithelial surface, (3) traverse the epithe-
hum, (4) pass through the basement membrane, and (5) encoun-
ter an acute inflammatory response which we observe as
pathologic and clinical evidence of pyelonephritis. Our intention
in this work was to examine steps (2) and (3), adherence to the
surface of the epithelium and one of the possible mechanisms of
epithelial passage, that is, cellular damage or death. For these
studies, we isolated and characterized a putative target cell, the
human renal tubular epithelial cell, and explored effects upon it of
an E. co/i strain isolated from a proven invasive (bacteremic) case
of human pyelonephritis.
Cytolethality
The results of experiments of cytolethahity support and extend
previous observations made in our laboratories.Our earlier exper-
iments quantitated HRPTEC death over several hours by mea-
surement of LDH release [7]. However, microscopic observations
revealed marked effects of CFTO73 upon HRPTEC by two or
three hours, a time by which measured release of LDH, a
molecule of large molecular weight (mol wt 134,000), was just
beginning. Consequently, we sought more sensitive assays for
measuring cell damage and death. Neutral red (mol wt = 288)
inclusion into and release from viable HRPTEC proved to be such
a method (Fig. 3) and allowed quantification of HRPTEC death
in a time frame consistent with our microscopic observations.
We observed significant killing of HRPTEC by the hemolysin-
producing pyelonephritogenic strain after one hour's incubation.
That hemolysin is the primary factor responsible for the cytolethal
effect is supported by two lines of evidence. First, the presence of
cytolethal activity in a bacterium-free filtrate is consistent with the
fact that hemolysin is one of the few E. coli proteins secreted into
the culture supernatant. Most importantly, a mutant with a
transposon insertion in the hlyD gene that is unable to express
hemolysin activity was significantly less cytolethal than the parent
strain from which it was derived. Though deficient in hemolysin
secretion, this mutant adhered as well as the parent strain to
HRPTEC, demonstrating that adherence alone is not sufficient
for cell killing.
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Bacterial-HRPTEC adherence
By electron microscopy we observed impressive adherence of
CFTO73 and the hemolysin-negative mutant to epithelial cells.
Furthermore, the observation of fimbria-like structures appar-
ently tethering the bacteria to the cells provides provocative
evidence that the adherence is due to these structures. CFTO73
possesses the genes and expresses the phenotypes associated with
at least three fimbria, type 1, P, and S. Was one of these fimbria
responsible for adherence?
Under growth conditions in which type 1 pili are expressed,
D-mannose, an inhibitor of type 1 binding, did not diminish
adherence of CFTO73 to HRPTEC. Furthermore, FN414, which
possesses the genes for and expresses type 1 fimbriae under
appropriate conditions, did not adhere as well as the pyelonephri-
tis strains. Thus, it is unlikely that type 1 fimbriae were responsible
for the adherence we observed.
P fimbriae are present in the majority of E. co/i strains causing
acute pyelonephritis in normal hosts. Importantly, receptors for P
fimbriae have been identified on human collecting duct, distal
tubular, and proximal tubular epithelium [15]. The possibility that
P fimbriae may have been responsible for the adherence we
observed is supported by three observations. Adherence was
reduced when the bacteria were grown at 25°C, a temperature at
which P fimbriae are not expressed, as confirmed by agglutination
studies. Adherence was diminished by antiserum that specifically
recognizes P fimbriae. Finally, adherence was inhibited by a
monoclonal antibody that recognizes the Gal-Gal moiety present
on the P fimbrial receptor. The fact that none of these treatments
completely blocked binding may be evidence that additional
adhesins, such as S fimbriae in this strain, also play a role in
Time, hours adherence under the conditions studied.
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Surveys of patients with acute pyelonephritis have reported that
30 to 60% of E. coil isolated from urine or blood were hemolytic
compared to only 5 to 15% of fecal E. coil from healthy controls
[2]. E. coil hemolysin is a 107 kD protein which is secreted only
during the exponential phase of bacterial growth [14]. The
secreted hemolysin of E. coii lyses erythrocytes by irreversibly
inserting into the erythrocyte membrane, forming a pore of about
two nm [16—19]. This water-filled channel allows fluxes of ions and
of uncharged molecules with consequent lysis of the erythrocyte
[16, 17]. Among the hypotheses put forth to explain the role of the
hemolysin of E. coli in clinical disease has been this venerable
effect, that is, lysis of erythrocytes, thus making iron available for
growth of the bacteria [4, 20]. However, to our knowledge there
are no data indicating lysis of erythrocytes is clinically relevant in
the pathogenesis of acute pyelonephritis. Even if this were so, we
believe that the present data indicate that the E. coii hemolysin
has a more direct role, that is, by causing death of the putative
target cell, the human renal epithelial cell. Support for our
hypothesis can be found in other studies demonstrating the lethal
effect of hemolysin on nucleated cells other than HRPTEC,
namely rat proximal tubule cells [21], pig endothelial cells [22],
and human leukocytes (including polymorphonuclear cells, lym-
phocytes, and monocytes [23].
Traversing the epithelium
The final set of experiments demonstrates that CFTO73 can
pass through an HRPTEC monolayer, a proxy for the in vivo
nephron whose tubular epithelial lining is a single cell layer.
CVFO73, following a lag period, passed through the monolayer,
reaching concentrations hundreds of times higher than that of its
hemolysin-negative mutant. The lag time before passage of
CFTO73 is consistent with bacterial adherence, growth, hemolysin
production and cytolethality and is similar to the lag time we
found in the cytolethality studies with whole bacteria. The obser-
vation that the hemolysin-negative mutant, CFTO73hyD::TnphoA,
was severely impaired in its ability to pass the epithelial barrier on
its own yet could pass when incubated with its hemolysin-positive
parent suggests a mechanism for monolayer penetration. We
propose that the parent bacteria which is cytolethal causes
epithelial cell damage sufficient to allow passage of the much less
cytolethal mutant. Light microscopic observations confirmed that
such damage occurs in vitro.
These findings prompt us to speculate upon the pathogenesis of
acute pyelonephritis caused byE. coli CFTO73. This organism has
a combination of genes which allows it to carry out a complex
sequence of activities. At each step, adhesins allow the organism
to establish niches in the colon, periurethral area, and bladder.
The organism must then ascend from the bladder to the kidney
where adhesins, prominently P fimbriae, allow it to bind to an
epithelial surface. We postulate that such adherence affords the
bacterium the means by which hemolysin may be delivered
efficiently and in relatively high concentration to the target cell
membrane. Although other functions of hemolysin are possible,
insertion of the hemolysin molecule into the eukaryotic cell
membrane may result in pore formation which leads to ion and
volume deregulation and death of the cell. The organism may
then traverse breaches in the epithelial cell barrier (and the
basement membrane by unknown means) and enter the intersti-
tium where the accumulating inflammatory response develops
into the clinical syndrome and pathologic findings of acute
pyelonephritis.
The epidemiologic prominence of P fimbriated, hemolytic E.
coil causing acute pyelonephritis [2—4] in vivo animal studies
showing synergy of P fimbriae and hemolysin in causing the
disease [24]; and these in vitro data with human renal epithelial
cells suggest that this sequence may be a frequent one in the
pathogenesis of acute pyelonephritis in humans.
Acknowledgments
This work was supported by Public Health Service grant AG04393 from
the National Institutes of Health. We acknowledge the technical assis-
tance of Michael O'Donnoghue in the adherence studies and Karen Jarvis
in the DNA hybridization studies. We thank Rich Hebel, Ph.D. for
statistical analysis of the data. Our thanks go to Linda Home for
manuscript preparation.
Reprint requests to Dr. Anna L. Trifillis, Univeristy of Maiyland School of
Medicine, Division of Infectious Diseases, 10 South Pine Street, Baltimore,
Maryland 21201-1192, USA.
References
1. U.S. DEPARTMENT OF HEALTH AND HUMAN SERvIcES: The National
Kidney and Urologic Diseases Advisory Board 1990 Long-Range Plan
Window on the 21st Centruty. Public Health Service, National Insti-
tutes of Health, NIH Publication Number 90-583, March 1990
2. JoHNsoN JR: Virulence factors in Escherichia coli urinary tract
infection. Clin Microbiol Rev 4:80—128, 1991
3. Orro 0, SANDBERG T, MARKLUND B-I, ULLERYD P, SvANnoRcI C:
Virulence factors and pap genotype in Escherichia coli isolates from
women with acute pyelonephritis, with or without bacteremia. Clin
Infect Dis 17:448—456, 1993
4. TULLE5 K, JACOBSON SH, KATOULI M, BRAUNER A: Relative impor-
tance of eight virulence characteristics of pyelonephritogenic Esche-
richia coli strains assessed by multivariate statistical analysis. I Urol
146:1153—1155, 1991
5. HUGHES C, HACKER J, ROBERTS A, GOEBEL W: Hemolysin production
as a virulence marker in symptomatic and asymptomatic urinary tract
infections caused by Escherichia colt Infect Immun 39:546—551, 1983
6. ROBERTS FJ, GEnRE 1W, COLDMAN A: A three-year study of positive
blood cultures, with emphasis on prognosis. I Infect Dis 13:34—46,
1991
7. MOBLEY HLT, GREEN DM, TRIFILLIS AL, JOHNSON DE, CHIvFENDALE
OR, LOCKATELL CV, JoNas BD, WARREN JW: Pyelonephritogenic B.
coli and killing of cultured human renal proximal tubular epithelial
cells: Role of hemolysin in some strains. Infect Immun 58:1281—1289,
1990
8. TRWIwS AL, REGEC AL, TRUMP BF: Isolation, culture and charac-
terization of human renal tubular cells. I Urol 133:324—329, 1985
9. ROSS MH, REITH El, ROMRELL LI: Histology—A Text and Atlas (2nd
ed). Baltimore, Williams & Wilkins, 1989, p. 51—84
10. SMim HW: The haemolysins of B. coli. I Path Bact 85:197—211, 1963
11. O'HAr.n.av P, Low D, ROMERO I, LARK D, VosTI K, FAI.KOw 5,
SCHOOLNIK 0: Gal-Gal binding and hemolysin phenotypes and geno-
types associated with uropathogenic Escherichia colt N EngI I Med
313:414—420, 1985
12. BORENFREIND E, PUERNER JA: Toxicity determined in vitro by mor-
phological alterations and neutral red absorption. ToxicolLett 24:119—
124, 1985
13. FINLAY BB, FUMBINER B, FALKOW 5: Penetration of Salmonella
through a polarized Madin-Darby Canine Kidney epithelial cell
monolayer. I Cell Biol 107:221—230, 1988
14. OROPEZA-WEKERLE RL, MULLER E, KERN P, MEYERMANN R,
GOEBEL W: Synthesis, inactivation, and localization of extracellular
and intracellular Escherichia coli hemolysins. I Bacteriol 171:2783—
2788, 1989
15. KORHONEN TK, VlRKoi.e R, HOLTHOFER H: Localization of binding
sites for purified Escherichia coli P fimbriae in the human kidney.
Infect Immun 54:328—332, 1986
Trifihlis et a!: Killing of human renal cells by E. co/i 1091
16. Bi-iMwi S, TRANUM-JENSEN J: Damage to cell membranes by pore-
forming bacterial cytolysins. Prog Allergy 40:1—42, 1987
17. BKDI S, MACKMAN N, NICAUD J-M, HOLLAND IB: Escherichia co/i
hemolysin may damage target cell membranes by generating trans-
membrane pores. Infect Immun 52:63—69, 1986
18. CAvuERI SJ, BOHACH GA, SNYDER IS: Escherichia co/i alpha-
hemolysin: Characteristics and probable role in pathogenicity. Micro-
biol Rev 48:326—343, 1984
19. MENESTRINA G, MACKMAN N, HOLLAND IB, BI-LAJW! S: Escherichia
co/i hemolysin forms voltage—dependent ion channels in lipid mem-
branes. Biochim Biophys 905:109-117, 1987
20. OP SM, CROSS AS, GEMSKI P, Lyirra LW: Aerobactin and a-he-
molysin as virulence determinants in Escherichia co/i isolated from
human blood, urine, and stool. J Infect Dis 161:794—796, 1990
21. KEANE WF, WELCH R, GEKKER G, PETERSON PK: Mechanism of
Escherichia co/i a-hemolysin-induced injury to isolated renal tubular
cells. Am J Pathol 126:350—357, 1987
22. SurroRl' N, FLOER B, SCHNITFLER H, SEEGER W, BI-IMWI 5: Effects of
Escherichia co/i hemolysin on endothelial cell function. Infrct Immun
58:3796—3801, 1990
23. GADEBERG OV, ORSKOV I: In vitro cytotoxic effect of alpha-hemolytic
Escherichia co/i on human blood granulocytes. Infect Immun 45:255—
260, 1985
24. O'HANLEY P, LALONDE G, GEON J: Alpha-hemolysin contributes for
the pathogenicity of piliated digalactoside-binding Escherichia co/i in
the kidney: Efficacy of an aipha-hemolysin vaccine in preventing renal
injury in the BALB/c mouse model of pyelonephritis. Infect Immun
59:1153—1161, 1991
